
Pegfilgrastim Biosimilars Global Market Report 2025
Description
Pegfilgrastim Biosimilars Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pegfilgrastim biosimilars market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for pegfilgrastim biosimilars ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pegfilgrastim biosimilars market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Application: Chemotherapy Treatment, Transplantation, Other Applications
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail-Order Pharmacies
Subsegments:
1) By Chemotherapy Treatment: Supportive Care for Cancer Patients; Reduction of Chemotherapy-Induced Neutropenia
2) By Transplantation: Hematopoietic Stem Cell Transplantation; Peripheral Blood Stem Cell Transplantation
3) By Other Applications: Treatment of Chronic Neutropenia; Treatment of Severe Congenital Neutropenia; Other Supportive Therapies in Oncology
Companies Mentioned: Amgen; Mylan N.V.; Sandoz (a Novartis division); Teva Pharmaceutical Industries Ltd.; Biocon
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
This report focuses on pegfilgrastim biosimilars market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pegfilgrastim biosimilars ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pegfilgrastim biosimilars market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Application: Chemotherapy Treatment, Transplantation, Other Applications
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail-Order Pharmacies
Subsegments:
1) By Chemotherapy Treatment: Supportive Care for Cancer Patients; Reduction of Chemotherapy-Induced Neutropenia
2) By Transplantation: Hematopoietic Stem Cell Transplantation; Peripheral Blood Stem Cell Transplantation
3) By Other Applications: Treatment of Chronic Neutropenia; Treatment of Severe Congenital Neutropenia; Other Supportive Therapies in Oncology
Companies Mentioned: Amgen; Mylan N.V.; Sandoz (a Novartis division); Teva Pharmaceutical Industries Ltd.; Biocon
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Pegfilgrastim Biosimilars Market Characteristics
- 3. Pegfilgrastim Biosimilars Market Trends And Strategies
- 4. Pegfilgrastim Biosimilars Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Pegfilgrastim Biosimilars Growth Analysis And Strategic Analysis Framework
- 5.1. Global Pegfilgrastim Biosimilars PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Pegfilgrastim Biosimilars Market Growth Rate Analysis
- 5.4. Global Pegfilgrastim Biosimilars Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Pegfilgrastim Biosimilars Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Pegfilgrastim Biosimilars Total Addressable Market (TAM)
- 6. Pegfilgrastim Biosimilars Market Segmentation
- 6.1. Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapy Treatment
- Transplantation
- Other Applications
- 6.2. Global Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Mail-Order Pharmacies
- 6.3. Global Pegfilgrastim Biosimilars Market, Sub-Segmentation Of Chemotherapy Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Supportive Care for Cancer Patients
- Reduction of Chemotherapy-Induced Neutropenia
- 6.4. Global Pegfilgrastim Biosimilars Market, Sub-Segmentation Of Transplantation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hematopoietic Stem Cell Transplantation
- Peripheral Blood Stem Cell Transplantation
- 6.5. Global Pegfilgrastim Biosimilars Market, Sub-Segmentation Of Other Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Treatment of Chronic Neutropenia
- Treatment of Severe Congenital Neutropenia
- Other Supportive Therapies in Oncology
- 7. Pegfilgrastim Biosimilars Market Regional And Country Analysis
- 7.1. Global Pegfilgrastim Biosimilars Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Pegfilgrastim Biosimilars Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Pegfilgrastim Biosimilars Market
- 8.1. Asia-Pacific Pegfilgrastim Biosimilars Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Pegfilgrastim Biosimilars Market
- 9.1. China Pegfilgrastim Biosimilars Market Overview
- 9.2. China Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Pegfilgrastim Biosimilars Market
- 10.1. India Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Pegfilgrastim Biosimilars Market
- 11.1. Japan Pegfilgrastim Biosimilars Market Overview
- 11.2. Japan Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Pegfilgrastim Biosimilars Market
- 12.1. Australia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Pegfilgrastim Biosimilars Market
- 13.1. Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Pegfilgrastim Biosimilars Market
- 14.1. South Korea Pegfilgrastim Biosimilars Market Overview
- 14.2. South Korea Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Pegfilgrastim Biosimilars Market
- 15.1. Western Europe Pegfilgrastim Biosimilars Market Overview
- 15.2. Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Pegfilgrastim Biosimilars Market
- 16.1. UK Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Pegfilgrastim Biosimilars Market
- 17.1. Germany Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Pegfilgrastim Biosimilars Market
- 18.1. France Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Pegfilgrastim Biosimilars Market
- 19.1. Italy Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Pegfilgrastim Biosimilars Market
- 20.1. Spain Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Pegfilgrastim Biosimilars Market
- 21.1. Eastern Europe Pegfilgrastim Biosimilars Market Overview
- 21.2. Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Pegfilgrastim Biosimilars Market
- 22.1. Russia Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Pegfilgrastim Biosimilars Market
- 23.1. North America Pegfilgrastim Biosimilars Market Overview
- 23.2. North America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Pegfilgrastim Biosimilars Market
- 24.1. USA Pegfilgrastim Biosimilars Market Overview
- 24.2. USA Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Pegfilgrastim Biosimilars Market
- 25.1. Canada Pegfilgrastim Biosimilars Market Overview
- 25.2. Canada Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Pegfilgrastim Biosimilars Market
- 26.1. South America Pegfilgrastim Biosimilars Market Overview
- 26.2. South America Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Pegfilgrastim Biosimilars Market
- 27.1. Brazil Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Pegfilgrastim Biosimilars Market
- 28.1. Middle East Pegfilgrastim Biosimilars Market Overview
- 28.2. Middle East Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Pegfilgrastim Biosimilars Market
- 29.1. Africa Pegfilgrastim Biosimilars Market Overview
- 29.2. Africa Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Pegfilgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Pegfilgrastim Biosimilars Market Competitive Landscape And Company Profiles
- 30.1. Pegfilgrastim Biosimilars Market Competitive Landscape
- 30.2. Pegfilgrastim Biosimilars Market Company Profiles
- 30.2.1. Amgen Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sandoz (a Novartis division) Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Biocon Overview, Products and Services, Strategy and Financial Analysis
- 31. Pegfilgrastim Biosimilars Market Other Major And Innovative Companies
- 31.1. Pfizer
- 31.2. Celltrion Healthcare
- 31.3. Coherus BioSciences
- 31.4. Gedeon Richter
- 31.5. Fresenius Kabi
- 31.6. Hetero Labs
- 31.7. Intas Pharmaceuticals
- 31.8. LG Chem
- 31.9. Merck KGaA
- 31.10. Zydus Cadila
- 31.11. Aurobindo Pharma
- 31.12. Apotex Inc.
- 31.13. Dr. Reddy's Laboratories
- 31.14. Stada Arzneimittel AG
- 31.15. Reddy's Laboratories
- 32. Global Pegfilgrastim Biosimilars Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Pegfilgrastim Biosimilars Market
- 34. Recent Developments In The Pegfilgrastim Biosimilars Market
- 35. Pegfilgrastim Biosimilars Market High Potential Countries, Segments and Strategies
- 35.1 Pegfilgrastim Biosimilars Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Pegfilgrastim Biosimilars Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Pegfilgrastim Biosimilars Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.